Related Experiment Video
Updated: May 7, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Impact of percutaneous left atrial appendage occlusion on the severity of ischemic stroke
Ahmed Maraey1, Hadeer Elsharnoby2, Mona Mahmoud1
1Division of Cardiovascular Medicine, University of Toledo Medical Center, Toledo, OH, United States of America.
Insights
Percutaneous left atrial appendage occlusion (pLAAO) reduces severe and fatal ischemic strokes in atrial fibrillation patients compared to anticoagulation. This finding suggests pLAAO may offer improved stroke outcome protection.
Area of Science:
- Cardiology
- Neurology
- Medical Devices
Background:
- Percutaneous left atrial appendage occlusion (pLAAO) is an alternative to anticoagulation (AC) for stroke prevention in atrial fibrillation (Afib) patients at high risk of bleeding.
- pLAAO has shown reduced rates of disabling stroke, primarily due to fewer hemorrhagic strokes.
- The impact of pLAAO on the severity of ischemic strokes remains understudied.
Purpose of the Study:
- To investigate the effect of pLAAO on the severity of ischemic strokes (IS) in patients with atrial fibrillation.
- To compare the outcomes of IS in patients treated with pLAAO versus those on AC.
Main Methods:
- Retrospective analysis of the National Readmission Database (2016-2020).
- Identified 6-month readmissions for IS after pLAAO and compared with Afib patients on AC admitted for IS.
- Utilized propensity score matching to control for confounding factors; excluded patients with intracranial hemorrhage or surgical LAAO.
Main Results:
- Matched analysis included 342 observations per group (weighted: 583 pLAAO vs. 663 AC).
- pLAAO was associated with a significantly decreased risk of fatal stroke (5.1% vs. 10.0%, OR 0.48, P=0.018).
- pLAAO also showed a decreased risk of non-fatal severe stroke at 6 months (50.5% vs. 59.6%, OR 0.69, P=0.029).
Conclusions:
- Patients with pLAAO experiencing ischemic strokes had a lower likelihood of severe and fatal outcomes compared to those on AC.
- These findings suggest pLAAO may offer superior protection against severe stroke outcomes.
- Further research is warranted to confirm these results.
Background:
Percutaneous left atrial appendage occlusion (pLAAO) presents an alternative to anticoagulation (AC) for stroke prophylaxis in atrial fibrillation (Afib) patients with high bleeding risk. pLAAO was associated with lower rates of disabling stroke which was mainly attributed to the reduction of hemorrhagic stroke (HS). Little is known about the impact of pLAAO on the severity of ischemic strokes which we sought to study.
Methods:
The study is a retrospective analysis of the National Readmission Database for the years 2016-2020. All 6-month readmissions with IS after pLAAO admissions were identified. The control group comprised patients with Afib on AC who were admitted for IS. Patients with intracranial hemorrhage or those who underwent surgical LAAO were excluded. A propensity score matching system was utilized to match both groups. Treatment effects were presented as percentages and odds ratio (OR) with 95 % confidence interval (CI).
Results:
A total of 342 observations in each group were matched (weighted estimate: 583 in the pLAAO group and 663 in the control group). pLAAO group was associated with a decreased risk of fatal stroke (5.1 % vs. 10.0 %, OR: 0.48, 95 % CI [0.26-0.88], P = 0.018), and a decreased risk of non-fatal severe stroke (50.5 % vs. 59.6 %, OR: 0.69, 95 % CI [0.50-0.96], P = 0.029) at 6 months follow-up.
Conclusion:
Compared with patients on AC, patients with pLAAO admitted with ischemic strokes are less likely to have severe and fatal stroke. Further studies are needed to validate our findings.
More Related Videos
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Pericarditis IV: Nursing Management
Heart Failure III: Clinical Manifestations

